Abstract: Provided in one embodiment is a method of forming an inorganic nanowire, comprising: providing an elongated organic scaffold; providing a plurality of inorganic nanoparticles attached to the organic scaffold along a length of the organic scaffold; and fusing the nanoparticles attached to the organic scaffold to form an inorganic nanowire.
Type:
Application
Filed:
August 27, 2013
Publication date:
July 31, 2014
Applicants:
Massachusetts Institute of Technology, Board of Regents, The University of Texas System
Inventors:
Angela M. BELCHER, Chuanbin MAO, Daniel J. SOLIS
Abstract: Several QTLs that are genetically linked to resistance to soybean cyst nematode (SCN) are disclosed. These QTLs have been mapped to genomic regions on Chrs. 4, 8, 10, 11, 18, and 20 of soybean, G. max. Candidate genes underlying these QTLs as defined by the flanking markers, as well as genetic markers associated with these QTLs are also disclosed. These markers can be utilized for introgressing SCN resistance into non-resistant soybean germplasm. The unique resistance genes can be introduced into a non-resistant plant by marker-assisted selection (MAS) or by transgenic methods.
Type:
Application
Filed:
April 4, 2014
Publication date:
July 31, 2014
Applicant:
The Curators of the University of Missouri
Inventors:
Henry T Nguyen, David A. Sleper, James G. Shannon, Tri D. Vuong, Xiaolei Wu
Abstract: The present invention is in the field of pharmaceuticals and chemical industries. In particular, the present invention relates to methods for labeling, imaging and detecting the beta-amyloid (A?) peptides, oligomers, and fibrils in vitro by using carbazole-based fluorophores. A further aspect of the present invention relates to a method of reducing and preventing aggregation of beta-amyloid peptides for Alzheimer's disease (AD) as well as of treating and/or preventing Alzheimer's disease by using carbazole-based fluorophores.
Type:
Application
Filed:
March 31, 2014
Publication date:
July 31, 2014
Applicant:
Hong Kong Baptist University
Inventors:
Lei GUO, Di XU, See-Lok HO, Chung-Yan POON, Olivia T. W. NG, Hung Wing LI, Ken K. L. YUNG, Daniel W. J. KWONG, Ricky M. S. WONG
Abstract: The present invention relates to an engineered bacteria for producing short chain fatty acid with the overexpression of a long chain (>C12) acyl-ACP thioesterases (long-TE) and a short chain (?C12) acyl-ACP thioesterases (short-TE).
Abstract: A power plant includes a boiler, a steam turbine, a generator driven by that steam turbine, a condenser, a post combustion processing system and an energy storage system including at least one electrochemical cell to store excess electrical energy generated by the generator during period valley demand and release thermal energy for power plant operations at other times.
Type:
Application
Filed:
January 28, 2014
Publication date:
July 31, 2014
Applicant:
University of Kentucky Research Foundation
Inventors:
Kunlei Liu, James Kyle Neathery, Joseph Eugene Remias, Cameron Anthony Lippert, Nick Edward Holubowitch
Abstract: An apparatus classifies touch events. The apparatus includes a touch sensitive surface configured to generate a touch event when an object touches the touch sensitive surface. The touch event entails a mechanical vibration upon contact with the surface. The apparatus includes a touch event detector configured to detect the onset of a touch, and a touch event classifier configured to classify the touch event to identify the object used for the touch event. The mechanical vibration is created via any one of finger parts including a tip, a pad, a fingernail, and a knuckle, each of which has a unique feature different from each other.
Type:
Application
Filed:
April 1, 2014
Publication date:
July 31, 2014
Applicant:
Carnegie Mellon University
Inventors:
Chris Harrison, Julia Schwarz, Scott E. Hudson
Abstract: The invention features methods of diagnosing cancer in a mammal (e.g., a human) by detecting a biomarker selected from a satellite II ribonucleic acid (RNA) molecule, a cancer-associated polycomb group (CAP) body, a cancer-associated satellite transcript (CAST) body, and UbH2A. Also featured is a method for identifying an agent for treating cancer in a mammal by contacting a cancer cell having a biomarker selected from a CAP body, a CAST body, and a satellite II RNA molecule with a test agent and determining whether the test agent reduces the level of the biomarker in the cancer cell. Other inventions featured are a method for determining whether a chemotherapeutic agent increases epigenetic imbalance of a cell and a method for detecting epigenetic imbalance by determining a copy number of a satellite II DNA locus at chromosome 1q12 in a cell.
Type:
Application
Filed:
July 16, 2012
Publication date:
July 31, 2014
Applicant:
University of Massachusetts
Inventors:
Jeanne B. Lawrence, Lisa Hall, Meg Byron, Dawn M. Carone
Abstract: The present disclosure provides biomarkers useful for determining the risk of, prognosis of, and/or diagnosis of conditions such as ischemic and/or non-ischemic heart failure in a subject.
Type:
Application
Filed:
January 27, 2014
Publication date:
July 31, 2014
Applicant:
Duke University
Inventors:
Dawn E. Bowles, Carmelo A. Milano, Valentino Piacentino, Matthew Schechter
Abstract: Isolated mixed populations of fetal pulmonary cells, engineered three-dimensional tissue constructs of these cells, and uses thereof in identifying therapeutic agents which augment, repair, and/or replace dysfunctional native lung and to perform in vitro studies such as pharmaceutical screening, models for lung development and disease and characterization of chemical or mechanical injury are provided.
Type:
Application
Filed:
December 9, 2013
Publication date:
July 31, 2014
Applicant:
Drexel University
Inventors:
Peter I. Lelkes, Mark J. Mondrinos, Christine M. Finck
Abstract: The present invention relates to a compound of formula XXII and a compound of formula 17ya, which are defined as anywhere in the specification, to a composition comprising the same, and to a method of using thereof in the treatment of various forms of cancer.
Type:
Application
Filed:
October 9, 2013
Publication date:
July 31, 2014
Applicants:
GTx, Inc., University of Tennessee Research Foundation
Inventors:
Duane D. Miller, Li Wei, Jianjun Chen, James T. Dalton, Chien-Ming Li, Sunjoo Ahn
Abstract: The invention provides virus-like particles for treatment of viral infections based on the virus causing the infection. The virus-like particles comprise the virus recombinant proteins that form a capsid, recombinant virus membrane proteins attached to the capsid and vRNA packaged within said capsid. The vRNA is generated from a DNA sequence encoding a polypeptide capable of specifically binding to a constant region of a nonstructural protein of the virus that is essential for propagation of the virus.
Type:
Application
Filed:
April 10, 2014
Publication date:
July 31, 2014
Applicant:
Ben Gurion University of The Negev Research and Development Authority
Abstract: Arrangements of pixel components that allow for full-color devices, while using emissive devices that use blue color altering layers in conjunction with blue emissive regions, that emit at not more than two colors, and/or that use limited number of color altering layers, are provided. Devices disclosed herein also may be achieved using simplified fabrication techniques compared to conventional side-by-side arrangements, because fewer masking steps may be required.
Type:
Application
Filed:
April 2, 2014
Publication date:
July 31, 2014
Applicant:
Universal Display Corporation
Inventors:
Michael Hack, Michael Stuart Weaver, Julia J. Brown, Xin Xu
Abstract: A method for isolating human neuroepithelial precursor cells from human fetal tissue by culturing the human fetal cells in fibroblast growth factor and chick embryo extract and immunodepleting from the cultured human fetal cells any cells expressing A2B5, NG2 and eNCAM is provided. In addition, methods for transplanting these cells into an animal are provided. Animals models transplanted with these human neuroepithelial precursor cells and methods for monitoring survival, proliferation, differentiation and migration of the cells in the animal model via detection of human specific markers are also provided.
Type:
Application
Filed:
March 18, 2014
Publication date:
July 31, 2014
Applicant:
University of Utah Research Foundation
Inventors:
Margot Mayer-Proschel, Mahendra S. Rao, Patrick A. Tresco, Darin J. Messina
Abstract: An MRI system acquires a susceptibility-weighted image by acquiring a first RF echo signal in a first echo time for providing an image exclusive of susceptibility-weighting and acquiring a second RF echo signal in a second echo time longer than the first echo time for providing an image including susceptibility-weighting. A compensation gradient field is applied for compensating for field inhomogeneity and in response, a third RF echo signal is acquired in a third echo time longer than the second echo time. First, second and third images are generated in response to data derived from the first, second and third RF echo signals respectively and data of the first, second and third images is combined to provide image data representing an image compensating for magnetic resonance signal attenuation in the second image.
Type:
Application
Filed:
January 29, 2014
Publication date:
July 31, 2014
Applicants:
The Trustees of the University of Pennsylvania, Samsung Electronics Co., Ltd.
Inventors:
Jin Young HWANG, Joon Soo KIM, Jae Moon JO, Yang Lim CHOI, Jongho LEE
Abstract: The present invention relates to a preparation method of implant comprising drug delivery layer and implant composition for living donor transplantation comprising the same, and more specifically, a preparation method of implant comprising drug delivery layer comprising preparing chitosan-bioactive glass composite solution; preparing drug-containing complex coating composition by adding drug in the chitosan-bioactive glass composite solution; and preparing drug delivery layer by electrophoresis of the complex coating composition on the surface of implant, and implant composition for living donor transplantation comprising the same. The implant composition according to the present invention is able to deliver the drug, and therefore to prevent inflammation, which may occur after the surgery, as well as to promote recovery depending on the type of drugs contained.
Type:
Application
Filed:
October 3, 2013
Publication date:
July 31, 2014
Applicant:
Industry-Academic Cooperation Foundation, Dankook University
Abstract: A synthetic peptide sequence demonstrating neuroprotective and anti-inflammatory functions is disclosed. Methods of use for the synthetic peptide are also provided.
Abstract: A component for use in a bearing device according to one embodiment of the present invention includes a lubricant layer on a surface of the component. Here, the lubricant layer contains a rod-like ionic liquid crystal compound having a cation group and an anion group.
Type:
Application
Filed:
January 17, 2014
Publication date:
July 31, 2014
Applicants:
Samsung Electro-Mechanics Japan Advanced Technolog Co., Ltd., BALBIS Co., LTD, University of Yamanashi
Abstract: Vaccine compositions and methods for protecting a mammalian subject against infection with S. pneumoniae are disclosed. These vaccine compositions include as the active ingredient a purified preparation of the cell wall protein ABC transporter substrate-binding protein having the Accession No. NP_344690 and the amino acid sequence set forth in SEQ ID NO: 32, optionally together with one or more pharmaceutically acceptable adjuvants.
Type:
Application
Filed:
February 19, 2014
Publication date:
July 31, 2014
Applicant:
Ben-Gurion University of the Negev Research and Development Authority
Abstract: It is an object of the present invention to provide a tissue staining method that makes it possible to observe both information on the morphology of a tissue and information on a biological substance such as an antigen molecule to be detected on a single section and in a single view field. The present invention provides a tissue staining method, including carrying out (A) a HE (hematoxylin-eosin) staining, and (B) a histochemical staining, serially on a single tissue section, wherein the histochemical staining is defined as a histochemical technique for detecting a biological substance to be detected in a tissue in a visible manner by use of a binding reaction between the biological substance to be detected and a probe biological substance capable of binding specifically to the biological substance to be detected.
Type:
Application
Filed:
September 4, 2012
Publication date:
July 31, 2014
Applicants:
Tohoku University, Konica Minolta, Inc.
Abstract: A motorcycle dashboard system adapted to be used with a motorcycle is disclosed. The motorcycle dashboard system includes a wireless communication unit, a micro processor and a display unit. The wireless communication unit is configured to receive an external information by way of wireless transmission. The micro processor, electrically connected to the wireless communication unit, is configured to receive and process the external information and accordingly output a first display information. The display unit, electrically connected to the micro processor, is configured to display the first display information.